{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:05:18Z","timestamp":1783476318349,"version":"3.55.0"},"reference-count":89,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Medical University of Lodz, Poland","award":["Grant No. 503\/3-011-01\/503-31-001"],"award-info":[{"award-number":["Grant No. 503\/3-011-01\/503-31-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Postpartum depression (PPD) remains a significant health concern worldwide. Both non-pharmacological and pharmacological treatments are available for patients with PPD; however, the standard approach involving selective serotonin reuptake inhibitors (SSRIs) and other antidepressants fails to provide a rapid response. This narrative review presents basic clinical and epidemiological data on PPD, summarizes currently used pharmacotherapies of PPD, highlights their limitations, and discusses new therapies based on a revised understanding of the disease\u2019s pathogenesis. Numerous studies indicate that dysregulation of GABAergic neurotransmission, which may result from fluctuating levels of neuroactive steroids during pregnancy and the postpartum period, plays an important role in the complex pathology of PPD. Considering this, neuroactive steroids, which act as positive allosteric modulators of central GABAA receptors (GABAARs), may offer new promising avenues for treating PPD. The first rapid-acting neurosteroid approved by the FDA to treat PPD in women is brexanolone, although its use is constrained by pharmacokinetic properties. The first oral neuroactive steroid-based antidepressant approved by the FDA for PPD is zuranolone. This review discusses the molecular mechanism of zuranolone action and the results of preclinical and clinical studies regarding the effectiveness and safety of the drug in treating PPD.<\/jats:p>","DOI":"10.3390\/ijms26136545","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:25:53Z","timestamp":1751941553000},"page":"6545","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuroactive Steroids as Novel Promising Drugs in Therapy of Postpartum Depression\u2014Focus on Zuranolone"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-2389","authenticated-orcid":false,"given":"Jolanta B.","family":"Zawilska","sequence":"first","affiliation":[{"name":"Department of Pharmacodynamics, Medical University of \u0141\u00f3d\u017a, Muszy\u0144skiego 1, 90-151 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-2580","authenticated-orcid":false,"given":"Ewa","family":"Zwierzy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, Medical University of \u0141\u00f3d\u017a, Muszy\u0144skiego 1, 90-151 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023). Depressive Disorder (Depression), WHO. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"ref_2","unstructured":"Balaram, K., and Marwaha, R. (2023). Postpartum Blues. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2022). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.]. Available online: https:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425787.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Clinical Practice Guidelines\u2013Obstetrics (2023). Screening and diagnosis of mental health conditions during pregnancy and postpartum. Clinical Practice Guideline No. 4. American College of Obstetricians and Gynecologists. Obstet. Gynecol., 141, 1232\u20131261.","DOI":"10.1097\/AOG.0000000000005200"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8403222","DOI":"10.1155\/2023\/8403222","article-title":"Prevalence of Postpartum Depression Based on Diagnostic Interviews: A Systematic Review and Meta-Analysis","volume":"2023","author":"Bai","year":"2023","journal-title":"Depress. Anxiety"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"152456","DOI":"10.1016\/j.comppsych.2024.152456","article-title":"Diagnosis of peripartum depression disorder: A state-of-the-art approach from the COST Action Riseup-PPD","volume":"130","author":"Akik","year":"2024","journal-title":"Compr. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/jwh.2011.3466","article-title":"Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005\u20132009","volume":"21","author":"Ko","year":"2012","journal-title":"J. Womens Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-clinpsy-101414-020426","article-title":"Biological and psychosocial predictors of postpartum depression: Systematic review and call for integration","volume":"11","author":"Yim","year":"2015","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Matsumura, K., Hamazaki, K., Tsuchida, A., Kasamatsu, H., Inadera, H., and Japan Environment and Children\u2019s Study (JECS) Group (2019). Education level and risk of postpartum depression: Results from the Japan Environment and Children\u2019s Study (JECS). BMC Psychiatry, 19.","DOI":"10.1186\/s12888-019-2401-3"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15585\/mmwr.mm6919a2","article-title":"Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression\u2014United States, 2018","volume":"69","author":"Bauman","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"110295","DOI":"10.1016\/j.jpsychores.2020.110295","article-title":"Risk factors for postpartum depression in Chinese women: A cross-sectional study at 6 weeks postpartum","volume":"140","author":"Shi","year":"2021","journal-title":"J. Psychosom. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"152239","DOI":"10.1016\/j.comppsych.2021.152239","article-title":"Psychosocial and peripartum determinants of postpartum depression: Findings from a prospective population-based cohort. The ABCD study","volume":"108","author":"Walker","year":"2021","journal-title":"Compr. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/jocn.16121","article-title":"Prevalence and risk factors of postpartum depression in women: A systematic review and meta-analysis","volume":"31","author":"Liu","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/01443615.2021.1980512","article-title":"Prevalence and associated psychological risk factors of postpartum depression: A cross-sectional study","volume":"42","author":"Cassinese","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_15","first-page":"267","article-title":"Peripartum Depression: Detection and Treatment","volume":"108","author":"Justesen","year":"2023","journal-title":"Am. Fam. Physician"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/1516-4446-2021-1952","article-title":"Peripartum anxiety: Parsing heterogeneity in clinical settings","volume":"441","author":"Sharma","year":"2022","journal-title":"Braz. J. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2015.04.021","article-title":"Suicidal ideation in depressed postpartum women: Associations with childhood trauma, sleep disturbance and anxiety","volume":"66\u201367","author":"Sit","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Orsolini, L., Valchera, A., Vecchiotti, R., Tomasetti, C., Iasevoli, F., Fornaro, M., De Berardis, D., Perna, G., Pompili, M., and Bellantuono, C. (2016). Suicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical Correlates. Front. Psychiatry, 7.","DOI":"10.3389\/fpsyt.2016.00138"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Eastwood, J.G., Jalaludin, B.B., Kemp, L.A., Phung, H.N., and Barnett, B.E. (2012). Relationship of postnatal depressive symptoms to infant temperament, maternal expectations, social support and other potential risk factors: Findings from a large Australian cross-sectional study. BMC Pregnancy Childbirth, 12.","DOI":"10.1186\/1471-2393-12-148"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-6712.2011.00925.x","article-title":"Depressive mood in women at childbirth predicts their mood and relationship with infant and partner during the first year postpartum","volume":"26","author":"Lilja","year":"2012","journal-title":"Scand. J. Caring Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Vismara, L., Roll\u00e8, L., Agostini, F., Sechi, C., Fenaroli, V., Molgora, S., Neri, E., Prino, L.E., Odorisio, F., and Trovato, A. (2016). Perinatal Parenting Stress, Anxiety, and Depression Outcomes in First-Time Mothers and Fathers: A 3- to 6-Months Postpartum Follow-Up Study. Front. Psychol., 7.","DOI":"10.3389\/fpsyg.2016.00938"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00737-015-0522-3","article-title":"Association between parental depressive symptoms and impaired bonding with the infant","volume":"19","author":"Kerstis","year":"2016","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_23","first-page":"e41381","article-title":"Postpartum Depression and Maternal Care: Exploring the Complex Effects on Mothers and Infants","volume":"15","author":"Saharoy","year":"2023","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamapsychiatry.2013.2163","article-title":"Maternal depression during pregnancy and the postnatal period: Risks and possible mechanisms for offspring depression at age 18 years","volume":"70","author":"Pearson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00737-015-0562-8","article-title":"Maternal depression from pregnancy to 4 years postpartum and emotional\/behavioural difficulties in children: Results from a prospective pregnancy cohort study","volume":"19","author":"Woolhouse","year":"2016","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapsychiatry.2017.4363","article-title":"Association of Persistent and Severe Postnatal Depression with Child Outcomes","volume":"75","author":"Netsi","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_27","first-page":"1745506519844044","article-title":"Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes","volume":"15","author":"Slomian","year":"2019","journal-title":"Womens Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamapediatrics.2020.2910","article-title":"Association Between Maternal Perinatal Depression and Anxiety and Child and Adolescent Development: A Meta-analysis","volume":"174","author":"Rogers","year":"2020","journal-title":"JAMA Pediatr."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Schwarze, C.E., Lerche, V., Wallwiener, S., and Pauen, S. (2024). Partnership quality and maternal depressive symptoms in the transition to parenthood: A prospective cohort study. BMC Pregnancy Childbirth., 4.","DOI":"10.1186\/s12884-024-06757-9"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jad.2018.11.062","article-title":"Course of a major postpartum depressive episode: A prospective 2 years naturalistic follow-up study","volume":"245","author":"Torres","year":"2019","journal-title":"J. Affect. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HRP.0000000000000013","article-title":"The course of postpartum depression: A review of longitudinal studies","volume":"22","author":"Vliegen","year":"2014","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, K., He, L., Li, Z., Ding, R., Han, X., Chen, B., Cao, G., Ye, J.H., Li, T., and Fu, R. (2024). Bridging Neurobiological Insights and Clinical Biomarkers in Postpartum Depression: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168835"},{"key":"ref_33","first-page":"Cd001134","article-title":"Psychosocial and psychological interventions for preventing postpartum depression","volume":"2","author":"Dennis","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2015.09.059","article-title":"Randomized controlled trial to prevent postpartum depression in mothers on public assistance","volume":"189","author":"Zlotnick","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/GRF.0000000000000388","article-title":"Psychotherapeutic treatments for depression during pregnancy","volume":"61","author":"Genovez","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/acps.13478","article-title":"Clinical practice guidelines with recommendations for peripartum depression: A European systematic review","volume":"146","author":"Motrico","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_37","first-page":"e76052","article-title":"Non-pharmacological Radical Methods for Treating Postpartum Depression Around the Globe: A Narrative Review","volume":"16","author":"Sushmitha","year":"2024","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11920-018-0937-4","article-title":"Neuroactive steroids and perinatal depression: A review of recent literature","volume":"20","author":"McEvoy","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Meltzer-Brody, S., and Kanes, S.J. (2020). Allopregnanolone in postpartum depression: Role in pathophysiology and treatment. Neurobiol. Stress, 12.","DOI":"10.1016\/j.ynstr.2020.100212"},{"key":"ref_41","first-page":"CD013560","article-title":"Antidepressant treatment for postnatal depression","volume":"2","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/NDT.S466260","article-title":"Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review","volume":"21","author":"Giannopoulos","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41386-023-01721-1","article-title":"Novel neurosteroid therapeutics for post-partum depression: Perspectives on clinical trials, program development, active research, and future directions","volume":"49","author":"Patterson","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1060028019873320","article-title":"Brexanolone (Zulresso): Finally, an FDA-approved treatment for postpartum depression","volume":"54","author":"Powell","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s40265-023-01953-x","article-title":"Zuranolone: First approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"ref_46","unstructured":"Chu, A., and Wadhwa, R. (2025). Selective Serotonin Reuptake Inhibitors. StatPearls [Internet], StatPearls Publishing. [Updated 1 May 2023]."},{"key":"ref_47","unstructured":"(2025, June 26). SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors). Available online: https:\/\/my.clevelandclinic.org\/health\/treatments\/24797-snri."},{"key":"ref_48","unstructured":"Moraczewski, J., Awosika, A.O., and Aedma, K.K. (2025). Tricyclic Antidepressants. StatPearls [Internet], StatPearls Publishing. [Updated 17 August 2023]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12031-023-02158-3","article-title":"Structure-function Studies of GABA (A) Receptors and Related computer-aided Studies","volume":"73","author":"Mohamad","year":"2023","journal-title":"J. Mol. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ghit, A., Assal, D., Al-Shami, A.S., and Hussein, D.E.E. (2021). GABAA receptors: Structure, function, pharmacology, and related disorders. J. Genet. Eng. Biotechnol., 19.","DOI":"10.1186\/s43141-021-00224-0"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pinna, G., Almeida, F.B., and Davis, M. (2022). Allopregnanolone in Postpartum Depression. Front. Glob. Womens Health, 3.","DOI":"10.3389\/fgwh.2022.823616"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107081","DOI":"10.1016\/j.psyneuen.2024.107081","article-title":"Allopregnanolone in the peripartum: Correlates, concentrations, and challenges\u2014A systematic review","volume":"166","author":"Ehlert","year":"2024","journal-title":"Psychoneuroendocrinolgy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","article-title":"Peripartum neuroactive steroid and \u03b3-aminobutyric acid profiles in women at-risk for postpartum depression","volume":"70","author":"Deligiannidis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biopsych.2023.01.022","article-title":"Impaired Endogenous Neurosteroid Signaling Contributes to Behavioral Deficits Associated with Chronic Stress","volume":"94","author":"Walton","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1111\/jne.12351","article-title":"Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research","volume":"28","author":"Porcu","year":"2016","journal-title":"J. Neuroendocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zorumski, C.F., Covey, D.F., Izumi, Y., Evers, A.S., Maguire, J.L., and Mennerick, S.J. (2025). New directions in neurosteroid therapeutics in neuropsychiatry. Neurosci. Biobehav. Rev., 172.","DOI":"10.1016\/j.neubiorev.2025.106119"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"18198","DOI":"10.1523\/JNEUROSCI.2560-11.2011","article-title":"Neurosteroidogenesis is required for the physiological response to stress: Role of neurosteroid-sensitive GABAA receptors","volume":"31","author":"Sarkar","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s00213-014-3572-8","article-title":"Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: What is the current state of knowledge in humans?","volume":"231","author":"Crowley","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Diotel, N., Charlierm, T.D., Lefebvre d\u2019Hellencourt, C., Couret, D., Trudeau, V.L., Nicolau, J.C., Meilhac, O., Kah, O., and Pellegrini, E. (2018). Steroid transport, local synthesis, and signaling within the brain: Roles in neurogenesis, neuroprotection, and sexual behaviors. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00084"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1074\/jbc.RA118.005543","article-title":"The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation","volume":"294","author":"Murugan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Balan, I., Beattie, M.C., O\u2019Buckley, T.K., Aurelian, L., and Morrow, A.L. (2019). Endogenous neurosteroid (3\u237a,5\u237a)3-hydroxypregnan-20-one inhibits toll-like-4 receptor activation and pro-inflammatory signaling in macrophages and brain. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-37409-6"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.psyneuen.2009.08.009","article-title":"Neurosteroids: Endogenous allosteric modulators of GABA(A) receptors","volume":"34","author":"Lambert","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: Regulation of subunit plasticity, phasic and tonic inhibition, and neuronal excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e13019","DOI":"10.1111\/jne.13019","article-title":"Development of neuroactive steroids for the treatment of postpartum depression","volume":"34","author":"Takahashi","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Chen, Z.W., Bracamontes, J.R., Budelier, M.M., Germann, A.L., Shin, D.J., Kathiresan, K., Qian, M.X., Manion, B., Cheng, W.W.L., and Reichert, D.E. (2019). Multiple functional neurosteroid binding sites on GABAA receptors. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000157"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Goldschen-Ohm, M.P. (2022). Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective. Biomolecules, 12.","DOI":"10.3390\/biom12121784"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Takasu, K., Yawata, Y., Tashima, R., Aritomi, H., Shimada, S., Onodera, T., Taishi, T., and Ogawa, K. (2024). Distinct mechanisms of allopregnanolone and diazepam underlie neuronal oscillations and differential antidepressant effect. Front. Cell. Neurosci., 17.","DOI":"10.3389\/fncel.2023.1274459"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biopsych.2021.07.017","article-title":"Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala","volume":"91","author":"Antonoudiou","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"ref_71","first-page":"F1000","article-title":"Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience","volume":"8","year":"2019","journal-title":"F1000Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: A randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jad.2022.09.143","article-title":"Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program","volume":"320","author":"Epperson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: Two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Colquhoun","year":"2018","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00213-023-06427-2","article-title":"Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: A landmark journey from concept to clinic in neurosteroid replacement therapy","volume":"240","author":"Reddy","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive Steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1H-pyrazol-1\u2019-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (\u03b3-Aminobutyric Acid)A Receptor","volume":"60","author":"Martinez","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_77","unstructured":"National Center for Biotechnology Information (2025, April 10). (2025) PubChem Compound Summary for CID 86294073, Zuranolone, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Zuranolone."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"108333","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40262-019-00801-0","article-title":"SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies","volume":"59","author":"Hoffmann","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"ref_80","unstructured":"Biogen Inc (2025, March 25). Zurzuvae (Zuranolone) [Package Insert]. FDA. Revised March 2019, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217369s000lbl.pdf."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"22m14475","DOI":"10.4088\/JCP.22m14475","article-title":"Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women with Postpartum Depression","volume":"84","author":"Deligiannidis","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of Zuranolone vs. Placebo in Postpartum Depression: A Randomized Clinical Trial","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.20220785","article-title":"Zuranolone for the Treatment of Postpartum Depression","volume":"180","author":"Deligiannidis","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jad.2024.01.268","article-title":"The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials","volume":"351","author":"Clayton","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Raja, A., Ahmed, S., Basit Ali Siddiqui, M., Lamiya Mir, S., Kumar, R., Ahmed, M., Raja, S., Bin Amin, S., Alim Ur Rahman, H., and Deepak, F. (2024). Evaluating the safety and efficacy of zuranolone in the management of major depressive disorder and postpartum depression, with or without concurrent insomnia: A rigorous systematic review and meta-analysis. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1425295"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/13696998.2024.2334160","article-title":"Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression","volume":"27","author":"Gerbasi","year":"2024","journal-title":"J. Med. Econ."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-024-06687-6","article-title":"Effects of zuranolone on next-day simulated driving in healthy adults","volume":"242","author":"Dunbar","year":"2025","journal-title":"Psychopharmacology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000001873","article-title":"Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals: Results from a Phase 1 Open-Label Study","volume":"44","author":"Deligiannidis","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euroneuro.2025.03.005","article-title":"Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov","volume":"96","author":"Swieczkowski","year":"2025","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6545\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:06:10Z","timestamp":1760033170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":89,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136545"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136545","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}